Adagio Medical Holdings Inc (ADGM)

$NAUT I’ve been digging through the SEC filings on Nautilus ($NAUT), Adagio ($ADGM), Immatics ($IMTX), and the Freenome deal, and it’s looking less like separate plays and more like one connected long-game by Perceptive Advisors. They brought all these companies public through their own SPACs ARYA I for IMTX (8-K ), ARYA II for NAUT (8-K ), ARYA IV for ADGM (S-1/A ), and now Freenome through another Perceptive SPAC (PCSC 8-K ). What stands out is how locked down the governance is, especially at NAUT their amended bylaws (Exhibit 3.2 to 8-K ) show a staggered board, super advance notice rules, no shareholder consent which isn’t normal for a small biotech. It’s built for control. Then there’s ADGM’s capital structure in their latest S-1 ), which shows a tiny float, like 21M shares, with a $24 price trigger for sponsor vesting just sitting there like a catalyst waiting

The B2i Digital team is pleased to announce Adagio Medical Inc. (Nasdaq: $ADGM ) is participating in the Small Cap Growth Virtual Investor Conference on Thursday, February 5, 2026. The Small Cap Growth Virtual Investor Conference (OTC Markets Group) is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/otc-market-vic-feb.-5th-26-small-cap-growth-virtual-investor-conference Virtual Investor Conferences brings together public companies and a global audience of individual and institutional investors for a full day of live, online presentations. The platform enables companies to present remotely, participate in live Q&A, and extend visibility through on-demand replays. Adagio Medical is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (UTLC) technology. UTLC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vClas™ catheter, which is CE Marked and is currently under evaluation in the FULCRUM-VT U.S. IDE Pivotal Study. For more information, please visit: https://investors.adagiomedical.com Presenting on behalf of the company will be Todd Usen, CEO. Adagio Medical is scheduled to present at 1:30 PM EST. To register and view the presentation, please visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5223002/adagio-medical-holdings-inc-nasdaq-adgm?utm_source=b2i&utm_medium=marketing&utm_campaign=0226SmallCapGrowthVIC For additional information about the Virtual Investor Conferences series, please visit www.virtualinvestorconferences.com. B2i Digital looks forward to supporting this conference connecting growth companies with the investor community. B2i Digital, Inc. is a privately held communications and marketing firm serving public and private companies. B2i Digital is not a broker-dealer or investment adviser. We do not offer, solicit, structure, negotiate, or execute securities transactions, and we do not provide investment advice or receive transaction-based compensation. Content shared here is for general information only and is not an offer to buy or sell any security. Any securities-related activities by our personnel are conducted solely through an appropriately registered broker-dealer, separate from services provided by B2i Digital.

$ADGM $BFRG both u can dump ur whole portfolio and u will make money, just watch and learn boys!

$ADGM c monn

$ADGM 🐢

$ADGM this will pop Off soon

$ADGM Ended green on the day. Is there hope?

$ADGM bought in heavy at .83 selling into 1.3 pump